Clinical Trial Update: Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and comparative bioavailability study of testosterone gel 1.62% in hypogonadal men, comparing application to the upper arms/shoulders wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• AndroGel 1.62% (testosterone gel 1.62%) (testosterone gel 1.62%)

Snippet

Sponsor: AbbVie | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED